Menu

Image of the Day: Mosquito Brain

Researchers have constructed the first neuroanatomy atlas of a female mosquito’s brain.

Mar 6, 2018
The Scientist Staff, The Scientist Staff

A reconstruction of a female Aedes aegypti brain shows distinct brain regions that connect to and communicate with one another to orchestrate mosquito behaviors.MEG YOUNGER/HOWARD HUGHES MEDICAL INSTITUTE/ROCKEFELLER UNIVERSITY

Researchers at Howard Hughes Medical Institute (HHMI) have mapped the neuroanatomical regions of the brain of a female mosquito (Aedes aegypti). The researchers constructed the map of groups of neurons by immunostaining the mosquito’s brain for Brp, a synaptic protein, and imaged the brain with confocal microscopy. The atlas was made freely available online on January 31st.

“We are trying to build the field of mosquito neurobiology,” says HHMI neurobiologist Leslie Vosshall, who led the work, in a press release. She says she hopes that the new atlas will let mosquito researchers from around the world share data and better understand which parts of the mosquito brain direct different behaviors.

“Somewhere in that female brain is the drive to sense humans, fly toward humans, land on humans, and bite and drink the blood of humans,” she says. “Somewhere in that brain is where decision making, motivation, and hunger reside.”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.

Thermo Fisher Scientific: Freezers for Biological Samples

Thermo Fisher Scientific: Freezers for Biological Samples

Fluctuations in temperature can reduce the efficacy, decompose, or shorten the shelf life of biologics. Therefore, it is important to store biologics at the right temperature using standardized protocols.